Assessing Interventions of Diet in IBD
AID-IBD
Understanding Patient's Barriers and Perceived Benefits Through Adherence to Nutritional Interventions in IBD: a Preliminary Study.
1 other identifier
interventional
45
1 country
3
Brief Summary
In this study, we are trying to learn how certain diets affect people with inflammatory bowel disease (IBD). We want to understand what makes it hard or easy for them to stick to different eating plans, like intermittent fasting, the Mediterranean diet, and the Low FODMAP diet. By finding out how these diets help with symptoms and which ones are easier to follow, we hope to improve the quality of life for people with IBD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2025
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 8, 2025
CompletedFirst Posted
Study publicly available on registry
January 14, 2025
CompletedStudy Start
First participant enrolled
April 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
ExpectedJune 26, 2025
June 1, 2025
1 year
January 8, 2025
June 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To identify IBD's top three patients' barriers to access and follow the nutritional intervention.
The outcome will be assessed through semi-structured one-on-one interviews conducted at the end of the study. Interviews will last approximately 40 minutes to 1 hour and will follow a structured interview guide with open-ended questions, designed to explore participants' experiences, perceptions, and challenges in accessing and adhering to the nutritional intervention. Interviews will be audio-recorded and transcribed verbatim. Data will be analyzed using thematic analysis informed by interpretive description methodology, to identify key personal and systemic barriers. NVivo software (QSR International) will be used to facilitate qualitative coding and analysis.
From enrollment to the end of the study and at 5 weeks
Secondary Outcomes (2)
To identify specific sociodemographic criteria that may act as a deterrent or facilitator in the ability to generate honest qualitative data through questionnaires and an individual interview.
From enrollment to the end of the study and at 5 weeks
To identify adherence to each food intervention through the use of an app (RxFood) and different questionnaires.
From enrollment to the end of the study and at 5 weeks
Study Arms (3)
Intermittent Fasting
EXPERIMENTALParticipants will be assigned to follow an intermittent fasting protocol.
Mediterranean Diet
EXPERIMENTALParticipants will be assigned to follow a Mediterranean diet.
Low FODMAP Diet
EXPERIMENTALParticipants will be assigned to follow a Low FODMAP Diet.
Interventions
A 14:10 intermittent fasting regimen, where participants fast for 14 hours and consume all meals within a 10-hour eating window daily.
A diet emphasizing whole grains, fruits, vegetables, olive oil, lean proteins, and minimizing processed foods.
A diet limiting fermentable oligosaccharides, disaccharides, monosaccharides, and polyols to manage gastrointestinal symptoms.
Eligibility Criteria
You may qualify if:
- Adults (18+ years) diagnosed with ulcerative colitis or Crohn's disease.
- Having willingness to use their personal smartphone to access the app
- Able to understand the indication by the registered dietitian.
- Able to provide informed consent.
- Willingness to attempt intervention diet and commit to study procedures.
You may not qualify if:
- Pregnant women.
- Currently being treated for eating disorders, schizophrenia, psychosis, or other acute mental disorders.
- Currently being treated for chemotherapy.
- Diabetes
- Advance chronic kidney disease
- Short bowl syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
2F Digestive Diseases Clinic - Hamilton Health Science
Hamilton, Ontario, L8N 3Z5, Canada
McMaster University
Hamilton, Ontario, L8S 4K1, Canada
McMaster University
Hamilton, Ontario, L8S 4K1, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 8, 2025
First Posted
January 14, 2025
Study Start
April 1, 2025
Primary Completion
April 1, 2026
Study Completion (Estimated)
January 1, 2027
Last Updated
June 26, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Data will be available after data completion - estimated 1 year
- Access Criteria
- The research team who will evaluate the interventions of diet in IBD
Approach investigators to ask for anonymized dataset